TrialCancer chemotherapy and pharmacology2018

Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.

Ingrid Jakobsen Falk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.